Norman Teh

Norman Teh possesses extensive experience in the pharmaceutical and biotechnology industries, currently serving as Interim Commercial Lead and Key Accounts Manager Lead for Antengene since March 2021, overseeing operations in Singapore and Hong Kong. Previously, Norman held the role of Senior Manager at Celgene from April 2014 to January 2019, focusing on enhancing business efficiencies, maximizing revenue, and aligning regional strategies with global objectives. Earlier positions included Scientific Advisor and Commercial Manager at Bristol-Myers Squibb and sales roles at Merck Serono and Janssen Pharmaceutical Companies of Johnson and Johnson, emphasizing oncology and haematology expertise. Norman holds a Bachelor of Science degree in Pharmacology and Molecular Biotechnology from the University of Sydney, completed in 2006.